Close
Back to SGEN Stock Lookup

Seagen (SGEN) – FDA

Dec 11, 2023 03:46 AM Seagen (SGEN) Reports ADCETRIS Plus Novel Immunotherapy Combination Delivers 100% PFS at 12 months in Phase 2 Trial
Dec 6, 2023 08:16 AM Seagen (SGEN) Announces TUKYSA in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves PFS in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer
Nov 30, 2023 05:00 PM
Nov 2, 2023 01:01 PM
Sep 22, 2023 05:29 AM
Sep 5, 2023 05:35 AM
Aug 16, 2023 08:00 AM
Jun 20, 2023 08:30 AM
Jun 15, 2023 05:59 AM
Jun 13, 2023 04:45 AM
Apr 3, 2023 05:01 PM
Jan 19, 2023 02:22 PM
Dec 20, 2022 06:47 AM
Nov 10, 2022 01:14 PM
Sep 27, 2022 08:03 AM
Sep 26, 2022 08:02 AM
Sep 19, 2022 08:01 AM
Sep 12, 2022 08:56 AM
Jul 26, 2022 05:54 AM
Jun 6, 2022 11:02 AM
Jun 3, 2022 03:13 PM
May 23, 2022 08:00 AM
Apr 8, 2022 01:19 PM
Mar 16, 2022 06:30 AM
Mar 16, 2022 06:20 AM
Feb 28, 2022 08:06 AM
Feb 24, 2022 10:01 AM
Feb 14, 2022 05:05 PM
Feb 3, 2022 08:03 AM
Jan 18, 2022 05:01 PM
Dec 17, 2021 06:40 AM
Dec 13, 2021 04:58 AM
Dec 9, 2021 05:55 AM
Sep 20, 2021 05:01 PM
Sep 20, 2021 05:39 AM
Jul 9, 2021 02:12 PM
Jun 7, 2021 06:31 AM
Jun 3, 2021 06:11 AM
May 19, 2021 05:21 PM
Apr 19, 2021 08:04 AM
Apr 9, 2021 04:00 PM
Mar 26, 2021 06:32 AM
Feb 18, 2021 08:03 AM
Feb 12, 2021 02:16 PM
Feb 12, 2021 06:48 AM
Feb 10, 2021 04:47 PM
Dec 11, 2020 07:23 AM
Oct 12, 2020 06:46 AM
Sep 21, 2020 10:20 AM
Sep 18, 2020 06:46 AM

Back to SGEN Stock Lookup